BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20631308)

  • 1. TLR4 activation is required for IL-17-induced multiple tissue inflammation and wasting in mice.
    Tang H; Pang S; Wang M; Xiao X; Rong Y; Wang H; Zang YQ
    J Immunol; 2010 Aug; 185(4):2563-9. PubMed ID: 20631308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock.
    Prince JM; Levy RM; Yang R; Mollen KP; Fink MP; Vodovotz Y; Billiar TR
    J Am Coll Surg; 2006 Mar; 202(3):407-17. PubMed ID: 16500244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo.
    Calippe B; Douin-Echinard V; Delpy L; Laffargue M; Lélu K; Krust A; Pipy B; Bayard F; Arnal JF; Guéry JC; Gourdy P
    J Immunol; 2010 Jul; 185(2):1169-76. PubMed ID: 20554954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Toll-like receptor 2 and 4 leads to differential induction of endoplasmic reticulum stress and proapoptotic responses in the intestinal epithelium under conditions of chronic inflammation.
    Messlik A; Schmechel S; Kisling S; Bereswill S; Heimesaat MM; Fischer A; Göbel U; Haller D
    J Proteome Res; 2009 Oct; 8(10):4406-17. PubMed ID: 19681597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 (TLR4)-dependent proinflammatory and immunomodulatory properties of the glycoinositolphospholipid (GIPL) from Trypanosoma cruzi.
    Medeiros MM; Peixoto JR; Oliveira AC; Cardilo-Reis L; Koatz VL; Van Kaer L; Previato JO; Mendonça-Previato L; Nobrega A; Bellio M
    J Leukoc Biol; 2007 Sep; 82(3):488-96. PubMed ID: 17540734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model.
    Shen XD; Ke B; Zhai Y; Gao F; Tsuchihashi S; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
    Liver Transpl; 2007 Oct; 13(10):1435-43. PubMed ID: 17902130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
    Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
    J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR4 activation mediates kidney ischemia/reperfusion injury.
    Wu H; Chen G; Wyburn KR; Yin J; Bertolino P; Eris JM; Alexander SI; Sharland AF; Chadban SJ
    J Clin Invest; 2007 Oct; 117(10):2847-59. PubMed ID: 17853945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4-independent and PKR-dependent interleukin 1 receptor antagonist expression upon LPS stimulation.
    Na HY; Mazumdar K; Moon HJ; Chang S; Seong SY
    Cell Immunol; 2009; 259(1):33-40. PubMed ID: 19559408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction.
    Satoh M; Shimoda Y; Maesawa C; Akatsu T; Ishikawa Y; Minami Y; Hiramori K; Nakamura M
    Int J Cardiol; 2006 May; 109(2):226-34. PubMed ID: 16051384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction.
    Yang QW; Li JC; Lu FL; Wen AQ; Xiang J; Zhang LL; Huang ZY; Wang JZ
    J Cereb Blood Flow Metab; 2008 Sep; 28(9):1588-96. PubMed ID: 18523439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion.
    Kaczorowski DJ; Nakao A; Mollen KP; Vallabhaneni R; Sugimoto R; Kohmoto J; Tobita K; Zuckerbraun BS; McCurry KR; Murase N; Billiar TR
    Transplantation; 2007 Nov; 84(10):1279-87. PubMed ID: 18049113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
    Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
    J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
    Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.
    Sharkhuu T; Matthaei KI; Forbes E; Mahalingam S; Hogan SP; Hansbro PM; Foster PS
    Clin Exp Allergy; 2006 Dec; 36(12):1575-83. PubMed ID: 17177681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation.
    Krasowska-Zoladek A; Banaszewska M; Kraszpulski M; Konat GW
    J Neurosci Res; 2007 Jan; 85(1):205-12. PubMed ID: 17061254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of toll-like receptor 4 in human alveolar epithelial cells and its role in cellular inflammation].
    Zhou M; Wan HY; Huang SG; Li B; Li M
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2112-6. PubMed ID: 19080471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells.
    Xu FL; You HB; Li XH; Chen XF; Liu ZJ; Gong JP
    Am J Surg; 2008 Jul; 196(1):139-48. PubMed ID: 18565339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
    Ii M; Matsunaga N; Hazeki K; Nakamura K; Takashima K; Seya T; Hazeki O; Kitazaki T; Iizawa Y
    Mol Pharmacol; 2006 Apr; 69(4):1288-95. PubMed ID: 16373689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.